Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | Nasdaq Biotechnology |
| Investment focus | Equity, United States, Health Care |
| Fund size | EUR 48 m |
| Total expense ratio | 0.35% p.a. |
| Replication | Physical (Optimized sampling) |
| Legal structure | ETF |
| Strategy risk | Long-only |
| Sustainability | No |
| Fund currency | USD |
| Currency risk | Currency unhedged |
| Volatility 1 year (in EUR) | 21.44% |
| Inception/ Listing Date | 5 March 2018 |
| Distribution policy | Distributing |
| Distribution frequency | Semi annually |
| Fund domicile | Ireland |
| Fund Provider | iShares |
| Fund Structure | Open-ended Investment Company (OEIC) |
| UCITS compliance | Yes |
| Administrator | State Street Fund Services (Ireland) Limited |
| Investment Advisor | |
| Custodian Bank | State Street Custodial Services (Ireland) Limited |
| Revision Company | Deloitte |
| Fiscal Year End | 31 May |
| Swiss representative | BlackRock Asset Management Schweiz AG |
| Swiss paying agent | State Street Bank International GmbH, Munich, Zurich Branch |
| Germany | 30% tax rebate |
| Switzerland | ESTV Reporting |
| Austria | Tax Reporting Fund |
| UK | UK Reporting |
| Indextype | Total return index |
| Swap counterparty | - |
| Collateral manager | Bank of New York Mellon|Euroclear|JP Morgan|State Street Bank |
| Securities lending | Yes |
| Securities lending counterparty | Barclays Bank Plc|Barclays Capital Securities Ltd.|BNP Paribas Arbitrage SNC|BNP Paribas SA|Citigroup Global Markets Ltd|Citigroup Inc|Credit Suisse Securities (Europe) Ltd.|Deutsche Bank AG|Goldman Sachs International|HSBC Bank Plc|J.P. Morgan Securities Plc|JP Morgan Chase & Co|Macquarie Bank Limited|Merrill Lynch International|Morgan Stanley & Co. International Plc|Nomura International Plc|Skandinaviska Enskilda Banken AB|Societe Generale SA|The Bank of Nova Scotia|UBS AG |
| Gilead Sciences, Inc. | 9.34% |
| Vertex Pharmaceuticals | 9.05% |
| Amgen, Inc. | 8.97% |
| Regeneron Pharmaceuticals, Inc. | 5.98% |
| Alnylam Pharmaceuticals | 3.29% |
| Insmed | 2.40% |
| Biogen, Inc. | 2.07% |
| argenx | 1.69% |
| United Therapeutics | 1.63% |
| Moderna, Inc. | 1.52% |
| United States | 80.86% |
| Bermuda | 1.49% |
| Ireland | 1.36% |
| Other | 16.29% |
| Health Care | 86.31% |
| Consumer Staples | 0.02% |
| Other | 13.67% |
| Broker | Rating | Execution fee | Account fee | |
|---|---|---|---|---|
| 0.00 € | 0.00 € | View offer** | |
| 0.00 € | 0.00 € | View offer* | |
| 0.00 € | 0.00 € | View offer* | |
| 0.00 € | 0.00 € | View offer* | |
| 0.00 € | 0.00 € | View offer* |
| Broker | Rating | Order fee | ETF savings plans | |
|---|---|---|---|---|
| 0.00 € | 3138 | View offer** | |
| 0.00 € | 1871 | View offer* | |
| 0.00 € | 2280 | View offer* | |
| 1.00 € | 2634 | View offer* | |
| 9.95 € | 1555 | View offer* |
| YTD | +3.56% |
| 1 month | +0.83% |
| 3 months | +1.39% |
| 6 months | +14.44% |
| 1 year | +45.97% |
| 3 years | +31.70% |
| 5 years | +29.90% |
| Since inception (MAX) | +80.65% |
| 2025 | +17.31% |
| 2024 | +5.34% |
| 2023 | +0.76% |
| 2022 | -5.13% |
| Current dividend yield | 0.37% |
| Dividends (last 12 months) | EUR 0.03 |
| Period | Dividend in EUR | Dividend yield in % |
|---|---|---|
| 1 Year | EUR 0.03 | 0.53% |
| 2025 | EUR 0.03 | 0.44% |
| 2024 | EUR 0.03 | 0.47% |
| 2023 | EUR 0.02 | 0.40% |
| 2022 | EUR 0.03 | 0.42% |
| Volatility 1 year | 21.44% |
| Volatility 3 years | 20.14% |
| Volatility 5 years | 22.45% |
| Return per risk 1 year | 2.14 |
| Return per risk 3 years | 0.48 |
| Return per risk 5 years | 0.24 |
| Maximum drawdown 1 year | -7.69% |
| Maximum drawdown 3 years | -25.58% |
| Maximum drawdown 5 years | -31.04% |
| Maximum drawdown since inception | -31.04% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | OM3E | - - | - - | - |
| London Stock Exchange | USD | BTEE | BTEE LN INAVBTDU | BTTE.L |
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| iShares Nasdaq US Biotechnology UCITS ETF | 753 | 0.35% p.a. | Accumulating | Sampling |
| Invesco Nasdaq Biotech UCITS ETF | 358 | 0.40% p.a. | Accumulating | Swap-based |